Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11391541rdf:typepubmed:Citationlld:pubmed
pubmed-article:11391541lifeskim:mentionsumls-concept:C0376325lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C0241910lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:11391541lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:11391541pubmed:issue6lld:pubmed
pubmed-article:11391541pubmed:dateCreated2001-6-6lld:pubmed
pubmed-article:11391541pubmed:abstractTextHLA alleles are known to be associated with susceptibility to develop autoimmune hepatitis (AH), and hepatitis A virus (HAV) infection is postulated as a putative trigger for AH. We investigated whether HLA may influence the outcome of the HAV infection by studying 67 children with self-limited and 39 children with protracted forms of this infection. HLA typing of the uncomplicated forms showed no significant increase of any HLA class I or II alleles. In contrast, DRB1*1301 was present in 46.1% of the children with protracted forms (vs. 9.8% in healthy controls; relative risk [RR]: 7.6; chi(2) = 33.3; P = 2 x 10(-9)). In uncomplicated hepatitis, 45% developed anti-smooth muscle antibody (SMA)/actin antibodies, but only 1 child had detectable antibodies after 3 months of infection onset. In contrast, after 1 year, 69% of the patients suffering protracted forms had titers of anti-SMA/actin antibodies that ranged between 1:40 and 1:160. Within their follow-up, 2 patients developed a Hashimoto's thyroiditis, but the remaining patients showed no signs of developing autoimmune hepatitis. We conclude that the DRB1*1301 haplotype is strongly associated with the protracted forms of HAV infection and suggest that the infection allows a sustained release of liver self-antigens. However, other still-unknown susceptibility genes are required for the full development of pediatric AH.lld:pubmed
pubmed-article:11391541pubmed:languageenglld:pubmed
pubmed-article:11391541pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11391541pubmed:citationSubsetIMlld:pubmed
pubmed-article:11391541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11391541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11391541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11391541pubmed:statusMEDLINElld:pubmed
pubmed-article:11391541pubmed:monthJunlld:pubmed
pubmed-article:11391541pubmed:issn0270-9139lld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:RoyAAlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:FainboimLLlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:CioccaMMlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:SalaLLlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:TheilerGGlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:ZelazkoMMlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:CapucchioMMlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:MarcosC YCYlld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:Cañero...lld:pubmed
pubmed-article:11391541pubmed:authorpubmed-author:NunciforaSSlld:pubmed
pubmed-article:11391541pubmed:issnTypePrintlld:pubmed
pubmed-article:11391541pubmed:volume33lld:pubmed
pubmed-article:11391541pubmed:ownerNLMlld:pubmed
pubmed-article:11391541pubmed:authorsCompleteYlld:pubmed
pubmed-article:11391541pubmed:pagination1512-7lld:pubmed
pubmed-article:11391541pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:meshHeadingpubmed-meshheading:11391541...lld:pubmed
pubmed-article:11391541pubmed:year2001lld:pubmed
pubmed-article:11391541pubmed:articleTitleProtracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis.lld:pubmed
pubmed-article:11391541pubmed:affiliationDivisión Inmunogenogenética, Hospital de Clínicas, and Departmento de Microbiología e Immunología, Facultad de Medicina, Universidad de Buenos Aires, Argentina. inmuno@fmed.uba.arlld:pubmed
pubmed-article:11391541pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11391541pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3123entrezgene:pubmedpubmed-article:11391541lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11391541lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11391541lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11391541lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11391541lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11391541lld:pubmed